We are proud to announce the expansion of our anticonvulsant therapeutic drug monitoring (TDM) offering to enhance personalized pharmacotherapy. Anticonvulsant drug level testing is available for the following: Perampanel (Fycompa) Oxcarbazepine (Trileptal) (including...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during March 2026 (epidemiological weeks 10-13). The data is dependent on submission of samples by clinicians and therefore may not be...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during February 2026 (epidemiological weeks 6-9). The data is dependent on submission of samples by clinicians and therefore may not be...
Infective endocarditis (IE) is a globally prevalent condition associated with high morbidity and mortality (1,2). Although historically rare, the annual estimated incidence has increased to 13.8 cases per 100 000 patients, attributable to an increased incidence of...
Clostridioides difficile infection (CDI) remains a leading cause of healthcare-associated diarrhoea and antibiotic-associated colitis. C. difficile produces 2 types of toxins; toxins A and B (encoded by TcdA & TcdB genes, respectively), which are virulence factors...
Recent heavy rainfall across South Africa has led to a continued rise in Malaria cases, with high transmission rates persisting in Mpumalanga and Limpopo, and increasing concern around "suitcase" (Odyssean) malaria in non-endemic areas. Vigilance remains...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during 2025. As with the monthly respiratory pathogen reports, the data is dependent on submission of samples by clinicians and therefore...
PathCare will now offer simultaneous measurement of salivary cortisol and cortisone using liquid chromatography–high-resolution mass spectrometry (LC-HRMS). This non-invasive, highly specific assay provides an accurate assessment of free cortisol exposure. When...
The Cancer Genome Atlas (TCGA) classifies endometrial cancer into four molecular subtypes: (1) POLE ultra-mutated, (2) Microsatellite unstable, (3) Abnormal p53 expression (p53 Abn) and (4) No specific molecular profile (NSMP), forming the basis of the Proactive...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during September 2025 (epidemiological weeks 36-39). The data is dependent on submission of samples by clinicians and therefore may not be...